DTC
GILD icon

Davidson Trust Company’s Gilead Sciences GILD Stock Holding History

Davidson Trust Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$262K Buy
1,879
+74
+4% +$10.4K 0.11% 150
2025
Q4 		$222K Sell
1,805
-145
-7% -$17.6K 0.09% 163
2025
Q3 		$216K Buy
+1,950
New +$222K 0.09% 165
2025
Q2 		– Sell
-1,808
Closed -$203K – 162
2025
Q1 		$203K Buy
+1,808
New +$187K 0.1% 161

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Davidson Trust Company's GILD Position: Q1 2026 in Review

Davidson Trust Company increased its Gilead Sciences (GILD) stake by 4.1% in Q1 2026, buying an estimated $10.4K and bringing the position to 1,879 shares worth $262K. The position accounts for 0.11% of the portfolio, ranked #150.

Davidson Trust Company first reported a position in GILD in Q1 2025 and has held it in 4 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Davidson Trust Company held 1,879 shares of Gilead Sciences worth $262K as of Q1 2026.
  • Davidson Trust Company bought 74 Gilead Sciences shares in Q1 2026, an estimated $10.4K.
  • Gilead Sciences made up 0.11% of Davidson Trust Company's portfolio in Q1 2026, its #150 holding.
  • Davidson Trust Company first reported a position in Gilead Sciences in Q1 2025 and has held it in 4 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Davidson Trust Company's 13F filing for Q1 2026, filed 20 Apr 2026.